Abstract:The majority of novel targeted anticancer drugs are weakly basic molecules with poor aqueous solubility which ultimately compromise their oral bioavailability. Lenvatinib (Lnv) is indicated for the first-line treatment of patients with hepatocellular carcinoma (HCC). Since it is a classical brick-dust molecule with extremely poor aqueous, organic solvent and oil solubility, Lnv formulation development is very challenging. We hypothesized that combining Lnv with valproic acid (a histone deacetylase (HDAC) inhibitor) will improve oil solubility and water hydrophobic ion pairing, as well as anticancer activity via synergistic interactions. Self-Nanoemulsifying Preconcentrate (SNEP) of Lnv was developed by screening and optimizing various biocompatible co-solvents, oils and non-ionic surfactants. Lnv and Valproic Acid (VA) loaded SNEP (LnVaNo) were optimized for kinetic stability, particle size, polydispersity index and in vitro release dissolution. In vitro c ytotoxicity of LnVaNo was investigated in comparison with the individual drugs using an MTT assay in three hepatic cancer cell lines (Hep3B, HepG2, and HuH6) along with migration and clonogenic assays. The anticancer efficacy was also analyzed in 3D multicellular hepatic tumor spheroids by tumor growth analysis and a Live/Dead cell assay. The interaction of Lnv with VA enhanced the solubilization and improved the kinetic stability of Lnv in nanoglobules. The optimized Lnv-VA system spontaneously formed a homogenous dispersion with a particle size <100 nm. LnVaNo showed a 3–4-fold enhancement in IC 50 against in the hepatic cancer cell lines compared to Lnv alone. Significantly higher red fluorescence (necrotic surface) and marked inhibition in tumor spheroid growth compared to the individual drug and control after 10 days of treatment indicated the superior efficacy of LnVaNo in tumor penetration and growth inhibition. Valproic acid facilitates molecular interaction to improve the solubility of weakly basic drugs and anticancer efficacy for the treatment of cancer.

Volasertib: Stable Complexes with Albumin and Encapsulation into Alginate/Montmorillonite Bionanocomposites

Multigram-scale synthesis of volasertib, an inhibitor of polo-like kinases in clinical evaluation

Development and In Vitro Evaluation of a Novel Drug Delivery System (Albumin Microspheres Containing Liposomes) Applied to Vancomycin

Investigation of antitumor activity and albumin interaction of new sulfosalicylate‐based complex by spectroscopic and computational approaches

Intercalation of the anticancer drug lenalidomide into montmorillonite for bioavailability improvement: a computational study

Microfluidic Encapsulation of Vorinostat in Calcium Alginate Microparticles: Prolonged Release and Enhanced in vitro Cytotoxicity

Albumin micro/nanoparticles entrapping liposomes for itraconazole green formulation

Bovine serum albumin binding, antioxidant and anticancer properties of an oxidovanadium(IV) complex with luteolin

Electrochemical and Theoretical Investigations on the Binding of Anticancer Drug Olaparib to Human Serum Albumin

Albumin anchored docetaxel lipid nanoemulsion for improved targeting efficiency - preparation, characterization, cytotoxic, antitumor and in vivo imaging studies

Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy

Efficacy and mechanism of action of volasertib, a potent and selective inhibitor of Polo-like kinases, in preclinical models of acute myeloid leukemia

Utilization of Lipophilic Salt and Phospholipid Complex in Lipid-Based Formulations to Modulate Drug Loading and Oral Bioavailability of Pazopanib

Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells

Lenvatinib-valproic acid self nanoemulsifying preconcentrate for the treatment of liver cancer

Preparation and characterization of cyclodextrin nanosponges for bortezomib delivery

Candesartan, losartan and valsartan Zn(II) complexes interactions with bovine serum albumin

Investigating the effect of polyvinylpyrrolidone matrix on surface characteristics and dissolution rate of anticancer drug dasatinib

Development of Novel EE/Alginate Polyelectrolyte Complex Nanoparticles for Lysozyme Delivery: Physicochemical Properties and In Vitro Safety

Drug-loaded oleic-acid grafted mesoporous silica nanoparticles conjugated with α-lactalbumin resembling BAMLET-like anticancer agent with improved biocompatibility and therapeutic efficacy

α3 integrin-binding peptide-functionalized polymersomes loaded with volasertib for dually-targeted molecular therapy for ovarian cancer